leisure time -WSS

leisure time

author：entertainment 2025-09-30 01:02:12 - browse：2557

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： UnitedHealth’s board chair also owns a personal investment firm

knowledge

WSS

PhRMA sues HHS over Medicare drug price negotiation

Option Care buys Amedisys in $3.6 billion home care deal

RaDonda Vaught case: a double standard for nurses, physicians

7 people shot in DC, police say

These geoengineering technologies could help combat the climate crisis, scientists say

Did the public have the right to know Arthur Ashe had AIDS?

entertainment

leisure time

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Listen: Biogen's messy board & Laronde's data problem

BioMarin wins approval for gene therapy to treat hemophilia A

These geoengineering technologies could help combat the climate crisis, scientists say

Alkermes shareholders re

A new study asks: Are we harming blood donors by taking blood?

New air purifier tech could be key to improving indoor air quality

PhRMA sues HHS over Medicare drug price negotiation

Medical leaders decry Supreme Court decision on affirmative action

STAT Summit: Biotech founders on deal

hotspot

PhRMA sues HHS over Medicare drug price negotiation

7 people shot in DC, police say

Australia's humpback populations rebound raising hopes of marine scientists

The EU Joint Clinical Assessment needs to live up to its promise

PhRMA sues HHS over Medicare drug price negotiation

Pfizer's Covid pill remains 89% effective in final analysis, company says

leisure time

hotspot

knowledge

hotspot